☆ 4.6 Article

Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice

JOURNAL OF VIROLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Bat coronaviruses related to SARS-CoV-2 and infectious for human cells

Sarah Temmam et al.

Summary: SARS-CoV-2-like bat viruses that are potentially infectious for humans circulate in Rhinolophus spp. in the Indochinese peninsula, and they can enter human cells through the hACE2 pathway, indicating the need for further understanding of the origin of the epidemic.

NATURE (2022)

Add to Collection

Article Infectious Diseases

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021

Lin T. Brandal et al.

Summary: In the Omicron SARS-CoV-2 outbreak in Oslo, Norway, most infected individuals were aged 30-50, 96% were vaccinated, with an attack rate of 74%, but none required hospitalization.

EUROSURVEILLANCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

C. Garrett Rappazzo et al.

Summary: The engineered antibody ADG-2 shows enhanced neutralization breadth and potency against a wide range of sarbecoviruses, providing complete protection in SARS and COVID-19 mouse models. Structural and biochemical studies reveal that ADG-2 targets a highly conserved epitope through a unique angle of approach.

SCIENCE (2021)

Add to Collection

News Item Multidisciplinary Sciences

OMICRON LIKELY TO WEAKEN COVID VACCINE PROTECTION

Ewen Callaway

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia

Supaporn Wacharapluesadee et al.

Summary: A study identified a SARS-CoV-2-related coronavirus (SC2r-CoV), RacCS203, in Rhinolophus acuminatus bats from Thailand, with 91.5% genome similarity to SARS-CoV-2, and demonstrated that sera obtained from bats and Malayan pangolin can neutralize SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Immunology

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape

Dandan Tian et al.

Summary: The Delta variant of the SARS-CoV-2 virus, first reported in India in October 2020 and classified as a variant of concern by the WHO in May 2021, is highly transmissible and associated with increased hospitalization, ICU admission, and mortality rates. It has become the dominant strain in many countries globally.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Highlights from a year in a pandemic

Miriam Merad et al.

Summary: Lessons learned from a year in the pandemic include significant scientific advancements, both successful and unsuccessful efforts to contain the disease, and the impact on global scientific discourse.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Geriatrics & Gerontology

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

Istvan Valyi-Nagy et al.

Summary: This study compared the humoral and T cell-mediated immune responses elicited by BBIBP-CorV and BNT162b2 vaccines against the SARS-CoV-2 virus, revealing significant quantitative and qualitative differences between the two. BBIBP-CorV vaccine induced high levels of antibody responses in healthy individuals, while BNT162b2 showed slightly higher T cell responses.

GEROSCIENCE (2021)

Add to Collection

Review Immunology

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy

Sindhu Ramesh et al.

Summary: The widespread increase in SARS-CoV-2 variants is causing significant health concerns globally, with four variants of concern and several variants of interest identified for close monitoring. These variants exhibit increased transmissibility and severity, with significant impacts on the immune system.

VACCINES (2021)

Add to Collection

Article Virology

Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates

Yan-Feng Yao et al.

Summary: The study demonstrated that an inactivated vaccine induced SARS-CoV-2-specific neutralizing antibodies in animals, providing partial or full protection. The results suggest the potential effectiveness of the vaccine in combating virus infection, offering hope for future human clinical trials.

VIROLOGICA SINICA (2021)

Add to Collection

Article Medicine, General & Internal

Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors

Chee-Wah Tan et al.

Summary: Survivors of SARS-CoV-1 infection who received the BNT162b2 mRNA vaccine produced potent cross-clade pan-sarbecovirus neutralizing antibodies, capable of neutralizing various variants of concern and potential human-infecting coronaviruses, indicating the feasibility of a pan-sarbecovirus vaccine strategy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice

David R. Martinez et al.

Summary: The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 has led to the development of universal vaccination strategies against the broader Sarbecovirus subgenus. Through the use of chimeric spike designs, high levels of broadly protective neutralizing antibodies have been induced against various high-risk Sarbecoviruses, showing potential for preventing SARS-like zoonotic coronavirus infections with pandemic potential.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

Pinja Jalkanen et al.

Summary: The study shows that the second dose of the BNT162b2 vaccine can induce cross-neutralization to some extent of SARS-CoV-2 variants, providing partial protection. Despite the reduced neutralization effect on the B.1.351 variant, the majority of vaccinees still have some level of protection.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Immunology

Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study

Xiao-Ning Li et al.

Summary: The two-dose inactivated SARS-CoV-2 vaccine showed an effectiveness of 59.0% to 70.2% against the Delta variant, with higher efficacy among participants aged 40-59 years and in females compared to males in preventing COVID-19 and moderate diseases.

EMERGING MICROBES & INFECTIONS (2021)

Add to Collection

Article Immunology

Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor

Hua Guo et al.

Summary: The study identified a new lineage of SARSr-CoVs, including RaTG15 and other viruses, in bats with characteristics similar to SARS-CoV-2 but distinct from known SARSr-CoVs. The results highlighted the need for further systematic and longitudinal research to prevent future cross-species transmission events caused by SARSr-CoVs or to better understand the origin of SARS-CoV-2.

EMERGING MICROBES & INFECTIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2

Ren-Di Jiang et al.

CELL (2020)

Add to Collection

Article Medicine, General & Internal

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

Shengli Xia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections

Ren Yang et al.

EBIOMEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Nina Le Bert et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Anna Z. Wec et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models

Ze-Jun Wang et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Microbiology

Complete Genome Sequence of a Severe Acute Respiratory Syndrome-Related Coronavirus from Kenyan Bats

Ying Tao et al.

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2019)

Add to Collection

Letter Biology

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses

Lei-Ping Zeng et al.

SCIENCE CHINA-LIFE SCIENCES (2017)

Add to Collection

Article Microbiology

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus

Ben Hu et al.

PLOS PATHOGENS (2017)

Add to Collection

Article Immunology

Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses

Jingxian Zhao et al.

SCIENCE IMMUNOLOGY (2017)

Add to Collection

Article Virology

Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response

Lei-Ping Zeng et al.

JOURNAL OF VIROLOGY (2016)

Add to Collection

Article Multidisciplinary Sciences

SARS-like WIV1-CoV poised for human emergence

Vineet D. Menachery et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection

Article Biochemistry & Molecular Biology

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

Vineet D. Menachery et al.

NATURE MEDICINE (2015)

Add to Collection

Article Multidisciplinary Sciences

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

Xing-Yi Ge et al.

NATURE (2013)

Add to Collection

Article Virology

Genomic Characterization of Severe Acute Respiratory Syndrome-Related Coronavirus in European Bats and Classification of Coronaviruses Based on Partial RNA-Dependent RNA Polymerase Gene Sequences

Jan Felix Drexler et al.

JOURNAL OF VIROLOGY (2010)

Add to Collection

Article Biotechnology & Applied Microbiology

Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis

Wuze Ren et al.

JOURNAL OF GENERAL VIROLOGY (2006)

Add to Collection

Article Multidisciplinary Sciences

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

SKP Lau et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Add to Collection

Article Medicine, General & Internal

Evidence of airborne transmission of the severe acute respiratory syndrome virus

ITS Yu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Add to Collection

Article Immunology

Antibodies to SARS coronavirus in civets

CC Tu et al.

EMERGING INFECTIOUS DISEASES (2004)

Add to Collection

Article Medicine, General & Internal

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003

NS Zhong et al.

LANCET (2003)

Add to Collection

Article Medicine, General & Internal

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

C Drosten et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.